retatrutide dosage in trials VisualAbstract: reduces body weight by 17.5% patients with obesity Watch This Video BEFORE Taking
Description
The drugs work by mimicking GLP-1, a hormone the gut releases after eating that stimulates insulin release and suppresses glucagon to control blood sugar
Tirzepatide targets both GLP-1 and GIP receptors, which earned it the "dual agonist" designation
Your dosage and medication remain the same
The relative components of the weight loss were not closely studied but it was assumed there was a mechanism to keep the composition of weight loss constant
Cold brew is genuinely better tolerated due to lower acid extraction
